FDA Inspection 924205 — Innovative Blood Resources, a Division of New York Blood Center, Inc.
The FDA completed an inspection of Innovative Blood Resources, a Division of New York Blood Center, Inc. on April 17, 2015 in Lincoln, NE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 17, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lincoln, NE (United States)